Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/41043
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcManus H.en
dc.contributor.authorPetoumenos K.en
dc.contributor.authorBrown K.en
dc.contributor.authorBaker D.en
dc.contributor.authorRussell D.en
dc.contributor.authorRead T.en
dc.contributor.authorSmith D.en
dc.contributor.authorWray L.en
dc.contributor.authorGiles M.en
dc.contributor.authorHoy J.en
dc.contributor.authorCarr A.en
dc.contributor.authorLaw M.G.en
dc.contributor.authorAustralian HIV Observational Databaseen
dc.date.accessioned2021-05-14T14:03:16Zen
dc.date.available2021-05-14T14:03:16Zen
dc.date.copyright2015en
dc.date.created20160618en
dc.date.issued2016-06-18en
dc.identifier.citationAntiviral Therapy. 20 (7) (pp 731-741), 2015. Date of Publication: 2015.en
dc.identifier.issn1359-6535en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/41043en
dc.description.abstractBackground: Loss to follow-up (LTFU) in HIV-positive cohorts is an important surrogate for interrupted clinical care, which can potentially influence the assessment of HIV disease status and outcomes. After preliminary evaluation of LTFU rates and patient characteristics, we evaluated the risk of mortality by LTFU status in a high-resource setting. Method(s): Rates of LTFU were measured in the Australian HIV Observational Database for a range of patient characteristics. Multivariate repeated measures regression methods were used to identify determinants of LTFU. Mortality by LTFU status was ascertained using linkage to the National Death Index. Survival following combination antiretroviral therapy initiation was investigated using the Kaplan-Meier (KM) method and Cox proportional hazards models. Result(s): Of 3,413 patients included in this analysis, 1,632 (47.8%) had at least one episode of LTFU after enrolment. Multivariate predictors of LTFU included viral load (VL)>10,000 copies/ml (rate ratio [RR] 1.63; 95% CI 1.45, 1.84; ref <=400), time under follow-up (per year; RR 1.03; 95% CI 1.02, 1.04) and prior LTFU (per episode; RR 1.15; 95% CI 1.06, 1.24). KM curves for survival were similar by LTFU status (P=0.484). LTFU was not associated with mortality in Cox proportional hazards models (univariate hazard ratio [HR] 0.93; 95% CI 0.69, 1.26) and multivariate HR 1.04 (95% CI 0.77, 1.43). Conclusion(s): Increased risk of LTFU was identified amongst patients with potentially higher infectiousness. We did not find significant mortality risk associated with LTFU. This is consistent with timely re-engagement with treatment, possibly via high levels of unreported linkage to other health-care providers.Copyright ©2015 International Medical Press.en
dc.languageenen
dc.languageEnglishen
dc.publisherInternational Medical Press Ltd (E-mail: imp@intmedpress.com)en
dc.relation.ispartofAntiviral Therapyen
dc.titleLoss to follow-up in the Australian HIV Observational Database.en
dc.typeArticleen
dc.type.studyortrialObservational study (cohort, case-control, cross sectional or survey)-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.3851/IMP2916en
dc.publisher.placeUnited Kingdomen
dc.identifier.source610617870en
dc.identifier.institution(McManus, Petoumenos, Law) Kirby Institute, UNSW Australia, Sydney, NSW, Australia (Brown) Illawarra Sexual Health Service, Warrawong, NSW, Australia (Baker) East Sydney Doctors, Sydney, NSW, Australia (Russell) Cairns Sexual Health Service, Cairns, QLD, Australia (Russell) James Cook University, Cairns, QLD, Australia (Russell) University of Melbourne, Melbourne, VIC, Australia (Read) Melbourne Sexual Health Centre, Alfred Health, Melbourne, VIC, Australia (Smith) Albion Centre, Sydney, NSW, Australia (Smith) School of Public Health and Community Medicine, University of New South Wales, Sydney, NSW, Australia (Wray) Sydney Sexual Health Centre, Sydney, NSW, Australia (Giles) Infectious Diseases, Monash Medical Centre, Melbourne, VIC, Australia (Giles) Department of Infectious Diseases, Monash University, Melbourne, VIC, Australia (Hoy) Department of Infectious Diseases, Alfred Hospital, Monash University, Melbourne, VIC, Australia (Carr) HIV, Immunology and Infectious Diseases Unit, St Vincent's Hospital, Sydney, NSW, Australiaen
dc.description.addressH. McManus, Kirby Institute, UNSW Australia, Sydney, NSW, Australia. E-mail: hmcmanus@kirby.unsw.edu.auen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2016 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailMcManus H.; hmcmanus@kirby.unsw.edu.auen
dc.description.grantNo: U01-AI069907 Organization: (NIAID) *Gilead Sciences* Organization: (NIH) *Gilead Sciences* Organization: *Gilead Sciences* Organization: (BMS) *Gilead Sciences*en
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Articles
Show simple item record

Page view(s)

20
checked on Sep 14, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.